News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current VERV market cap is 516.77M. The company's latest EPS is USD -2.3926 and P/E is -2.58.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 929k | 1.01M | 1.4M | 2.09M | 3.12M |
| Operating Income | -43.86M | -47.71M | -58.26M | -58.58M | -52.33M |
| Net Income | -45.19M | -41.09M | -51.98M | -53.98M | -45.76M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 1.94M | 11.76M |
| Operating Income | -13.64M | -40.63M | -87.07M | -165.69M | -223.12M |
| Net Income | -19.3M | -45.7M | -120.31M | -157.39M | -200.07M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 673.36M | 679.22M | 634.38M | 589.13M | 612.41M |
| Total Liabilities | 125.41M | 128.29M | 124.9M | 123.91M | 152.04M |
| Total Equity | 547.94M | 550.93M | 509.48M | 465.22M | 460.37M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 21.65M | 78.41M | 384.12M | 679.22M | 752.69M |
| Total Liabilities | 15.72M | 17.16M | 26.77M | 128.29M | 153.19M |
| Total Equity | -19.55M | -63.91M | 357.35M | 550.93M | 599.5M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -89.44M | -122.33M | -49.1M | -97.06M | -108.87M |
| Investing | 12.36M | -155.96M | 15.39M | 48.42M | 36.58M |
| Financing | 289.36M | 328.96M | 2.04M | 3.27M | 35.19M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.44M | -35.27M | -77.88M | -122.33M | -149.55M |
| Investing | -12.76M | -51.13M | -239.1M | -155.96M | 27.69M |
| Financing | 17.95M | 92.63M | 377.09M | 328.96M | 212.58M |
| Market Cap | 516.77M |
| Price to Earnings Ratio | -2.58 |
| Price to Sales Ratio | 43.95 |
| Price to Cash Ratio | 2.51 |
| Price to Book Ratio | 0.86 |
| Dividend Yield | - |
| Shares Outstanding | 83.62M |
| Average Volume (1 week) | 1.04M |
| Average Volume (1 Month) | 1.69M |
| 52 Week Change | -60.69% |
| 52 Week High | 21.4199 |
| 52 Week Low | 6.02 |
| Spread (Intraday) | 0.01 (0.16%) |
| Company Name | Verve Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.vervetx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
